Pieter Sonneveld (Peter Sonneveld)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 40

Top Topics

Multiple Myeloma

Newly Diagnosed

Total Hip Arthroplasty

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) (2024)
Madelon M E de Jong, Cathelijne Fokkema, Natalie Papazian, Ágnes Czeti, Marjolein K Appelman, Michael Vermeulen, Teddie van Heusden, Remco M Hoogenboezem, Gregory van Beek, Sabrin Tahri, Mathijs A Sanders, Pieter C van de Woestijne, Francesca Gay, Philippe Moreau, Maike Büttner-Herold, Heiko Bruns, Mark van Duin, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma. Nature immunology 25 (5) (2024)
Monique C Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula F Ypma, Ka Lung Wu, Marie José Kersten, Sandra Croockewit, Sonja Zweegman, Lidwine W Tick, Annemiek Broijl, Harry Koene, Gerard M J Bos, Pieter Sonneveld, Stefan O Schönland
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients. EJHaem 5 (4) (2024)
Madelon M E de Jong, Cathelijne Fokkema, Natalie Papazian, Ágnes Czeti, Marjolein K Appelman, Michael Vermeulen, Teddie van Heusden, Remco M Hoogenboezem, Gregory van Beek, Sabrin Tahri, Mathijs A Sanders, Pieter C van de Woestijne, Francesca Gay, Philippe Moreau, Maike Büttner-Herold, Heiko Bruns, Mark van Duin, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma. Nature immunology (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Monique C Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula F Ypma, Ka Lung Wu, Marie José Kersten, Sandra Croockewit, Sonja Zweegman, Lidwine W Tick, Annemiek Broijl, Harry Koene, Gerard M J Bos, Pieter Sonneveld, Stefan O Schönland
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients. EJHaem 5 (4) (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) 20 (17) (2024)
Madelon M E de Jong, Cathelijne Fokkema, Natalie Papazian, Ágnes Czeti, Marjolein K Appelman, Michael Vermeulen, Teddie van Heusden, Remco M Hoogenboezem, Gregory van Beek, Sabrin Tahri, Mathijs A Sanders, Pieter C van de Woestijne, Francesca Gay, Philippe Moreau, Maike Büttner-Herold, Heiko Bruns, Mark van Duin, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma. Nature immunology 25 (5) (2024)
Madelon M E de Jong, Cathelijne Fokkema, Natalie Papazian, Ágnes Czeti, Marjolein K Appelman, Michael Vermeulen, Teddie van Heusden, Remco M Hoogenboezem, Gregory van Beek, Sabrin Tahri, Mathijs A Sanders, Pieter C van de Woestijne, Francesca Gay, Philippe Moreau, Maike Büttner-Herold, Heiko Bruns, Mark van Duin, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma. Nature immunology 25 (5) (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) 20 (17) (2024)
Sabrin Tahri, Sara Piccinelli, Nang Kham Su, Luisa M Lampe, Han Dong, Juliana Vergara Cadavid, Rebecca Boiarsky, Natalie Papazian, Elizabeth D Lightbody, Amanda Cao, Jean-Baptiste Alberge, Lucas Ferrari de Andrade, Mahshid Rahmat, Yujia Shen, Laura Blanco-Fernández, Aintzane Zabaleta, Andreas Guenther, Gad Getz, Pieter Sonneveld, Tom Cupedo, Kai W Wucherpfennig, Irene M Ghobrial, Rizwan Romee
Inhibition of MICA and MICB shedding enhances memory-like NK cell-mediated cytotoxicity against multiple myeloma. Blood advances (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) 20 (17) (2024)
Elias Karl Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Sonja Zweegman, Marc-Steffen Raab, Markus Munder, Lucia Pantani, Katia Mancuso, Peter Brossart, Meral Beksac, Igor W Blau, Jan Dürig, Britta Besemer, Roland Fenk, Peter Reimer, Bronno van der Holt, Mathias Hänel, Ivana von Metzler, Ullrich Graeven, Carsten Muller-Tidow, Mario Boccadoro, Christof Scheid, Meletios- Athanasios Dimopoulos, Jens Hillengass, Katja C Weisel, Michele Cavo, Pieter Sonneveld, Hartmut Goldschmidt
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients. Leukemia (2023)
Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos-Manteca, Hartmut Goldschmidt, Kenshi Suzuki, Mark-David Levin, Pieter Sonneveld, Robert Z Orlowski, Sung Soo Yoon, Saad Z Usmani, Katja C Weisel, Donna Reece, Tahamtan Ahmadi, Huiling Pei, Wendy Garvin Mayo, Xue Gai, Jodi Carey, J Blake Bartlett, Robin Carson, Meletios-Athanasios A Dimopoulos
Daratumumab in Myeloma Patients With Early or Late Relapse After Initial Therapy: Subgroup Analysis of CASTOR and POLLUX. Blood advances (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Schjesvold Fredrik, Heinz Ludwig, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Haifaa Abdulhaq, Stefan Norin, Marcus Thuresson, Nicolaas A Bakker, Paul Gerard Richardson, Pieter Sonneveld
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study. European journal of haematology (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Maria-Victoria Mateos-Manteca, Katja C Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michele Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W C J van de Donk, Enrique M Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodriguez-Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesús San F Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma. Leukemia 36 (5) (2022)
Mirian Brink, Monique C Minnema, Otto Visser, Mark-David Levin, Eduardus F M Ward Posthuma, Annemiek Broijl, Pieter Sonneveld, Marjolein van der Klift, Wilfried W H Roeloffzen, Matthijs Westerman, Cleo R van Rooijen, Paulus A F Geerts, Sonja Zweegman, Niels W C J van de Donk, Avinash G Dinmohamed
Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands. Blood cancer journal 12 (3) (2022)
Evangelos Terpos, Meletios- Athanasios Dimopoulos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Phillipe Moreau, Alessandra Pompa, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Katharine S Gries, John Fastenau, Kevin Liu, Jianming He, Tobias Kampfenkel, Yanping Qiu, Himal Amin, Robin Carson, Pieter Sonneveld
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial. American journal of hematology 97 (4) (2022)
Davine Hofste Op Bruinink, Rowan Kuiper, Mark van Duin, Tom Cupedo, Vincent H J van der Velden, Remco M Hoogenboezem, Bronno van der Holt, H Berna Beverloo, Erik T Valent, Michael Vermeulen, Francesca Gay, Annemiek Broijl, Herve Avet-Loiseau, Nikhil C Munshi, Pellegrino Musto, Phillipe Moreau, Sonja Zweegman, Niels W C J van de Donk, Pieter Sonneveld
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Pieter Sonneveld, Asher Chanan-Khan, Katja Weisel, Ajay K Nooka, Tamas Masszi, Meral Beksac, Ivan Spicka, Vania Tietsche de Moraes Hungria, Markus Munder, Maria-Victoria Mateos-Manteca, Tomer M Mark, Mark-David Levin, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Andrew Spencer
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Mirian Brink, Kaz Groen, Pieter Sonneveld, Monique C Minnema, Annemiek Broijl, Avinash G Dinmohamed, Ellen van der Spek, Mark-David Levin, Paula F Ypma, Esther de Waal, Eduardus F M Ward Posthuma, Sonja Zweegman, Niels W C J van de Donk
Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study. Blood cancer journal 11 (11) (2021)
Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek, Yavuz M Bilgin, Alain Kentos, Maaike Sohne, Roel J W van Kampen, Inge Ludwig, Noortje Thielen, Nazik Durdu-Rayman, Nicole C H P de Graauw, Niels W C J van de Donk, Esther G M de Waal, Marie-Christiane Vekemans, Gert Jan Timmers, Marjolein van der Klift, Savita Soechit, Paulus A F Geerts, Matthijs H Silbermann, Margriet Oosterveld, Inger S Nijhof, Pieter Sonneveld, Saskia K Klein, Mark-David Levin, Sonja Zweegman
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (25) (2021)
Heinz Ludwig, Jesús San-Miguel, Nikhil Munshi, Pieter Sonneveld, María-Victoria Mateos, Phillipe Moreau, Evangelos Terpos
Covid-19 vaccination in patients with multiple myeloma: Focus on immune response. American journal of hematology 96 (8) (2021)
Madelon M E de Jong, Zoltán Kellermayer, Natalie Papazian, Sabrin Tahri, Davine Hofste Op Bruinink, Remco Hoogenboezem, Mathijs A Sanders, Pieter C van de Woestijne, P Koen Bos, Cyrus Khandanpour, Jessica Vermeulen, Philippe Moreau, Mark van Duin, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nature immunology 22 (6) (2021)
Carlos Fernández de Larrea, Robert Kyle, Laura Rosinol, Juan José Lahuerta, Monika Engelhardt, Saad Z Usmani, Jo Caers, Wilson Gonsalves, Schjesvold Fredrik, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha A Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin F Kaiser, Jesús San F Miguel, Joan Bladé, Sundararajan Vincent Rajkumar, Maria-Victoria Mateos-Manteca
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood cancer journal 11 (12) (2021)
Pieter Sonneveld, Meletios- Athanasios Dimopoulos, Meral Beksac, Bronno van der Holt, Sara Aquino, Heinz Ludwig, Sonja Zweegman, Thilo Zander, Elena Zamagni, Ruth Wester, Roman Hajek, Lucia Pantani, Luca Dozza, Francesca Gay, AnneMaria Cafro, Luca De Rosa, Annamaria Morelli, Henrik Gregersen, Nina Gulbrandsen, Petra Cornelisse, Rosella Troia, Stefania Oliva, Vincent H J van der Velden, Ka Lung Wu, Paula F Ypma, Gerard M J Bos, Mark-David Levin, Luca Pour, Christoph Driessen, Annemiek Broijl, Alexandra Croockewit, Monique C Minnema, Anders Waage, Cecilie Hveding Blimark, Niels W C J van de Donk, Massimo Offidani, Giuseppe Alberto Maria Palumbo, Andrew Spencer, Mario Boccadoro, Michele Cavo
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)
Ajai Chari, Paul G Richardson, Dorothy Romanus, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Evangelos Terpos, Roman Hajek, Aditya Raju, Antonio Palumbo, Lauren E Cain, Marlo Blazer, Hui Huang, Eileen Farrelly, Sikander Ailawadhi
Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd. Expert review of hematology 13 (4) (2020)
Elena Zamagni, Cristina Nanni, Luca Dozza, Thomas Carlier, Clément Bailly, Paola Tacchetti, Annibale Versari, Stephane Chauvie, Andrea Gallamini, Barbara Gamberi, Denis Caillot, Francesca Patriarca, Margaret Macro, Mario Boccadoro, Laurent Garderet, Simona Barbato, Stefano Fanti, Aurore Perrot, Francesca Gay, Pieter Sonneveld, Lionel Karlin, Michele Cavo, Caroline Bodet-Milin, Philippe Moreau, Françoise Kraeber-Bodéré
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (2) (2020)
Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Hartmut Goldschmidt, Pieter Sonneveld, Meletios- Athanasios Dimopoulos, Bart Heeg, Mahmoud Hashim, William Deraedt, Peter Hu, Annette Lam, Jianming He
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison. Leukemia & lymphoma 61 (3) (2019)